Equity · Healthcare
PTCT
PTC Therapeutics, Inc. · NasdaqGS
The line runs $69 on 22 May through $79 on 17 July, on a scale from $60 to $100. Days the market did not trade hold the previous close, flat.
The chart above plots the price of PTCT over the range selected — one day to the full history — drawn by TradingView from their own data. Our own licensed end-of-day series holds 38 sessions over that window: $69 on 22 May 2026 through $79 on 17 July 2026.
Finazon · prior-day close · valuation computed from SEC EDGAR filings · as of Aug 20, 2026
PTCT insider trades
Showing the 12 most recent of 15 open-market trades in this window. The figures above count all of them.
Compensation mechanics Share grants, option exercises, tax withholding and transfers. They reach the same Form 4 as a trade, but they are not the insider buying or selling on the open market, so no purchase or sale value applies to them.
Showing the 12 most recent of 14 compensation filings in this window. The figures above count all of them.
PTCT reported financials
PTCT reported revenue of $1.7B for the fiscal year ended 31 Dec 2025. Net income over the same period was $682.6M.
Source: SEC EDGAR XBRL company facts · latest period ended 30 Jun 2026
PTCT earnings
no date announced in SEC filings yet
Reported figures & scheduled dates · SEC EDGAR filings
PTCT institutional holders
10 of the 45 institutional funds we track reported a PTCT position for the quarter ended 30 Jun 2026 — a combined $341.7M; the latest of those filings landed 14 Aug 2026.
Source: SEC EDGAR 13F filings
PTCT fails-to-deliver
On 29 Jul 2026, 39 shares of PTCT failed to deliver (about $3K) — the latest of 2 consecutive trading days with recorded fails.
Source: SEC fails-to-deliver (CNS) data